Literature DB >> 15730136

27 kDa Fasciola gigantica glycoprotein for the diagnosis of prepatent fasciolosis in cattle.

S Ghosh1, Preeti Rawat, R Velusamy, David Joseph, S C Gupta, B P Singh.   

Abstract

An indirect enzyme-linked immunosorbent assay (ELISA) using 27 kDa glycoprotein of Fasciola gigantica has been evaluated for its potential use in the diagnosis of bovine fasciolosis. Following experimental infection of rabbits, F. gigantica infection-induced antibodies were isolated and later used as ligands in affinity chromatography for isolation of infection-induced antibody-specific proteins. Among the five infection-specific proteins isolated, a glycoprotein of 27 kDa was later isolated by second-step purification using concanavalin A matrix. In crossbred cattle receiving different doses of infection (100, 200 and 400 metacercariae), the anti-27 kDa antibodies were detected as early as the 2nd week post infection. No direct correlation between initial dose, antibody response and fluke establishment was recorded. No cross-reaction was noted with the sera of goats experimentally infected with Paramphistomum epiclitum. ELISA with the 27 kDa glycoprotein could be a feasible diagnostic tool for the early detection of bovine fasciolosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15730136     DOI: 10.1023/b:verc.0000047497.57392.8c

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  30 in total

1.  Cross-bred cattle protected against Hyalomma anatolicum anatolicum by larval antigens purified by immunoaffinity chromatography.

Authors:  S Ghosh; M H Khan; N Ahmed
Journal:  Trop Anim Health Prod       Date:  1999-10       Impact factor: 1.559

2.  Herd evaluation by enzyme-linked immunosorbent assay for the determination of Fasciola hepatica infection in sheep and cattle from the Altiplano of Bolivia.

Authors:  G V Hillyer; M Soler de Galanes; P Buchón; J Bjorland
Journal:  Vet Parasitol       Date:  1996-02       Impact factor: 2.738

3.  The use of monoclonal antibody for the immunodiagnosis of Fasciola gigantica infection in cattle.

Authors:  B O Fagbemi; O A Aderibigbe; E E Guobadia
Journal:  Vet Parasitol       Date:  1997-05       Impact factor: 2.738

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Methods of isolation, purification and quantitation of bovine immunoglobulins: a technical review.

Authors:  H Fey; H Pfister; J Messerli; N Sturzenegger; F Grolimund
Journal:  Zentralbl Veterinarmed B       Date:  1976-05

6.  28 kDa Fasciola gigantica cysteine proteinase in the diagnosis of prepatent ovine fasciolosis.

Authors:  A K Dixit; S C Yadav; R L Sharma
Journal:  Vet Parasitol       Date:  2002-11-11       Impact factor: 2.738

7.  Use of a pre-selected epitope of cathepsin-L1 in a highly specific peptide-based immunoassay for the diagnosis of Fasciola hepatica infections in cattle.

Authors:  J B Cornelissen; C P Gaasenbeek; W Boersma; F H Borgsteede; F J van Milligen
Journal:  Int J Parasitol       Date:  1999-05       Impact factor: 3.981

8.  An optimized enzyme-linked immunosorbent assay for quantitative diagnosis of bovine fascioliasis.

Authors:  J H Wyckoff; R E Bradley
Journal:  J Parasitol       Date:  1986-06       Impact factor: 1.276

9.  Humoral and cellular immune responses to Fasciola hepatica experimental primary and secondary infection in sheep.

Authors:  A Chauvin; G Bouvet; C Boulard
Journal:  Int J Parasitol       Date:  1995-10       Impact factor: 3.981

10.  Detection of antibodies of Fasciola hepatica excretory--secretory antigens in experimentally infected goats by enzyme immunosorbent assay.

Authors:  A Martínez; M S Martínez-Cruz; F J Martínez; P N Gutierrez; S Hernández
Journal:  Vet Parasitol       Date:  1996-04       Impact factor: 2.738

View more
  8 in total

1.  Characterization of specific and cross-reacting antigens of Fasciola gigantica by immunoblotting.

Authors:  S Yokananth; S Ghosh; S C Gupta; M G Suresh; D Saravanan
Journal:  Parasitol Res       Date:  2005-06-11       Impact factor: 2.289

2.  Immunoaffinity chromatographic analysis for purification of specific diagnostic antigens of Paramphistomum epiclitum.

Authors:  Ritu Arora; N K Singh; P D Juyal; S Ghosh
Journal:  J Parasit Dis       Date:  2010-10-08

3.  Early detection of Fasciola gigantica infection in buffaloes by enzyme-linked immunosorbent assay and dot enzyme-linked immunosorbent assay.

Authors:  Niranjan Kumar; S Ghosh; S C Gupta
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

4.  Detection of Fasciola gigantica infection in buffaloes by enzyme-linked immunosorbent assay.

Authors:  Niranjan Kumar; S Ghosh; S C Gupta
Journal:  Parasitol Res       Date:  2008-09-10       Impact factor: 2.289

5.  The role of Ser-(Arg-Ser-Arg-Ser-GlucNAc)19-GlucNAc Fasciola gigantica glycoprotein in the diagnosis of prepatent fasciolosis in rabbits.

Authors:  Eman H Abdel-Rahman; Azza H Mohamed; Adel A H Abdel-Rahman; Eman E El Shanawany
Journal:  J Parasit Dis       Date:  2014-04-26

6.  Diagnostic efficacy of monoclonal antibody based sandwich enzyme linked immunosorbent assay (ELISA) for detection of Fasciola gigantica excretory/secretory antigens in both serum and stool.

Authors:  Zeinab A Demerdash; Tarek M Diab; Ibrahim R Aly; Salwa H Mohamed; Faten S Mahmoud; Mona K Zoheiry; Wafaa A Mansour; Mohy E Attia; Azza E El-Bassiouny
Journal:  Parasit Vectors       Date:  2011-09-15       Impact factor: 3.876

7.  Evaluation of antibody response to various developmental stage specific somatic antigens of Paramphistomum epiclitum in goats.

Authors:  A Prasad; Nirbhay Kumar Singh
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

8.  Immunolocalization and immunodetection of the excretory/secretory (ES) antigens of Fasciola gigantica.

Authors:  M A Hannan Khan; Rizwan Ullah; Abdur Rehman; Lubna Rehman; Ahammed Shareef P A; S M A Abidi
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.